Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Feb/03/2022 60 0
mRNA-1273 Emergency use authorization Experimental Vaccine Feb/03/2022 25 0
Baricitinib Emergency use authorization Used to treat other disease Other treatment Feb/03/2022 33 2
T cells Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/15/2021 14 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/22/2021 36 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 87 22
(E)-4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)furan-2-yl)Methylene)-3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid Potential treatment - theoretical effect Experimental Other treatment Apr/12/2021 1 0
Palbociclib Potential treatment - theoretical effect Used to treat other disease Other treatment Apr/12/2021 3 0
Naproxol Potential treatment - theoretical effect Experimental Other treatment Apr/12/2021 1 0
Amsacrine Potential treatment - theoretical effect Used to treat other disease Other treatment Apr/12/2021 1 0